m m m m m m m m mm
Nursing Practice 12th Edition Geralyn Frandsen(complete G
m m m m m mm
uide)Latest 2023 100% Graded
m m m
,Abrams'mClinicalmDrugmTherapy:mRationalesmformNursingmPracticem12thmEditionmFrandsen mTestmBa
nk
Abrams' Clinical Drug Therapy: Rationales for
m m m m m m
Nursing Practice 12th Edition Fran
m m m m
dsen Test Bank m m
,Abrams'mClinicalmDrugmTherapy:mRationalesmformNursingmPracticem12thmEditionmFrandsen mTestmBa
nk
Chapterm1m ThemFoundationmofmPharmacology:mQuality mandmSafety
Amwoman mhasmbeen mprescribed mparoxetine mhy
drochloride,mwhich misman mantidepressantmagent
madministered min mpillmform. mThe mmedication mis
1.
madministered mformhermobsessive-
compulsive mdisorder.mThismmedication mwillmpr
oduce mwhich mof mthemfollowingmeffects?
A) Curative
B) Systemic
C) Local
D) Parenteral
Ans: B
Feedback:
Drugsmthatmproduce msystemic meffectsmaremtaken
minto mthe mbody, mcirculated mthrough mthe mbloodst
reammto mtheirmsitesmof maction min mvariousmbody mt
issues,mand meventually meliminated mfrommthembo
dy.mCurativemagentsmaremgiven mto mcuremamdiseas
emprocess.mIn mthismcase,mparoxetine mhydrochlor
idemwillmcontrolmthemsymptomsmbutmnotmcuremth
emdisorder.mDrugsmwith mlocalmeffects,msuch masm
sunscreen mand mlocalmanesthetics, mactmmainly mat
mthe msite mof mapplication. mParoxetine mhydrochlo
ridemism notm administered mparenterally.mParente
ralmagentsmarem administered msubcutaneously, mi
ntramuscularly, mormintravenously.
Ampatientmhasmbeen mprescribed man mantibiotic.m
Thismmedication mismamnaturally moccurringmsubs
2. tancemthatmhasmbeen mchemically mmodified.
Whatmismanothermname mformthismtypemof mmedica
tion?
A) Synthetic m drug
B) Semisynthetic m drug
C) Biotechnology m drug
D) Prototype mdrug
Ans: B
Feedback:
, Abrams'mClinicalmDrugmTherapy:mRationalesmformNursingmPracticem12thmEditionmFrandsen mTestmBa
nk
Semisynthetic mdrugsm(e.g.,mmany mantibiotics)ma
remnaturally moccurringmsubstancesmthatmhavembe
en mchemically mmodified.mSynthetic mdrugsmarem
moremstandardized min mtheirmchemicalmcharacter
istics,mmoremconsistentm in m theirmeffects,mand mle
ssmlikely mto mproduce mallergicmreactions.mBiotec
hnology mdrugsminvolve mmanipulatingm DNAman
d m RNAmand mrecombiningmgenesminto mhybrid m
moleculesmthatmcan mbeminserted minto mlivingmorg
anisms.
Prototype mdrugsmaremthemfirstmdrugmof mampartic
ularmgroup mto mbemdeveloped.
Ampatientmismadministered mmorphine.mMorphin
emismamprototypicalmdrugmthatmcan mbemclassified
3.
min
differentmways.mWhich mofmthemfollowingmclassi
ficationsmappliesmto mmorphine?
A) Centralm nervousm systemm depressant
B) Centralm nervousmsystem m stimulant
C) Anti-inflammatory
D) Antihypertensive
Ans: A
Feedback:
Drugsmaremclassified maccordingmto mtheirmeffects
mon mparticularmbody msystems, mtheirmtherapeutic
muses, mand mtheirmchemicalmcharacteristics. mForm
example,mmorphine mcan mbemclassified masmamcen
tralmnervousmsystem mdepressantmand mamnarcotic
mormopioid manalgesic. mAmcentralmnervous msyste
mmstimulantm increasesm attention m and mraisesmm
ood.mAn manti-
inflammatory magentmdecreasesminflammation ma
tmthemsitemof mtissuemormjointminflammation. mAn m
antihypertensive magentmreducesmblood mpressure
.
Ampatientmismadministered mamoxicillin m(Amoxi
l).mThemgeneric mnamemof mthis
4.
medication mindicatesmthatmitmbelongsmto mwhich
mdrugmgroup?
A) Selectivem serotonin m reuptake m inhibitors
B) Diuretics
C) Penicillins
D) ACEm inhibitors
Ans: C